Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP

Recruiting now · Not applicable

Conditions studied: Benign Prostatic Hyperplasia

In brief

Holmium laser enucleation (HOLEP) has became a standard of treatment of large prostates that indicates surgery. HOLEP is widely used nowadays. Many settings are used but no optimal setting was world wide adopted. The aim of this trial is to assess the Low-power Holmium laser enucleation of the prostate (LP-HoLEP)and compare to high-power (HP-HoLEP) for enucleation efficiency pertaining to the advantages of lower cost and minimal postoperative dysuria, storage symptoms, and negative sexual impact.

Key facts

Study ID

NCT05678452

Run by

Al-Azhar University

People needed

200

Starts

2022-01-01

Expected to finish

2025-09-01

Last updated by the study team

2024-08-15

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• large prostate indicated for surgical intervention.

You may not qualify if…

• prostate cancer
• recurrent adenomas
• associated neurologic factors that may affect outcomes (e.g., neurogenic bladder)

Where it is running

• Urology department - AlAzhar university — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.